Effect of suppository bases on the release properties of a potent antimicrobial agent (C31G)

Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
Pharmazie (Impact Factor: 1.05). 06/1994; 49(5):336-9.
Source: PubMed


C31G is a specific formulation which contains equal molar concentrations of alkyl N-betaine and alkyl N,N-dimethylamine oxide. Vaginal suppositories containing 500 mg of C31G, this potent antimicrobial substance, were prepared by the fusion method in a variety of Suppocire and Witepsol bases with different melting points and hydroxyl values. In vitro release and diffusion characteristics of C31G from different suppository bases were investigated using two different systems. The release from suppositories was determined by using a system without a membrane and the diffusion rate of the released agent was determined through a semipermeable dialyzing tubing. Diffusion kinetics from suppositories were evaluated in terms of the apparent dialytic rate constants using the equation developed by Davis et al. From the results of in vitro studies, Witepsol H15 and Suppocire CM bases were selected as the most suitable ones for the formulations of C31G vaginal suppositories, since it is imperative for topical formulations to release the active substance in high proportions which are not absorbable by the mucosal membranes.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The factors involved in mechanisms of availability of different drugs from suppositories with lipophilic excipients were studied by using an in vitro model of the rectal compartment with a porous membrane simulating the rectal barrier. The solubility in water of drugs was found to be the fundamental factor influencing the release rate from suppositories. In fact, following the melting of the suppository at body temperature the drug particles can migrate to the interface with the small volume of rectal secretion where they dissolve. Drug molecules can so diffuse until they come into contact with the rectal barrier through which the drug is absorbed. Drug concentration in the intrarectal aqueous phase produces the gradient against the large volume of the plasma phase. This gradient regulates the diffusion rate through the barrier. A drug with a low water solubility saturates the intrarectal phase at low concentration hindering the subsequent dissolution of the drug particles remaining in the melted excipient. This fact maintains the viscosity of the melted suppository at a ligh level, which slows the migration of the particles. On the other hand, a drug with high water solubility quickly leaves the excipient, producing a high concentration in the intrarectal phase which supports a high diffusion rate across the barrier. The results obtained indicate that drugs with low solubility in water result in low availability, while drugs with good solubility can give an intense and rapid drug supply for a rapid and intense therapeutic response with the dose administered almost completely utilised.
    Full-text · Article · Jun 2000 · Pharmazie
  • [Show abstract] [Hide abstract]
    ABSTRACT: Salmon calcitonin (sCT) is a polypeptide hormone consisting of 32 amino acid residues (MW approx. 3400 Da), which can be used successfully for the treatment of osteoporosis, Paget's disease and hypercalcaemia. Only nasal and parenteral preparations of sCT are currently available, and as injections are poorly accepted by patients, nonparenteral preparations for oral, rectal and nasal administration are highly desirable. However, oral sCT is poorly bioavailable, being susceptible to enzymatic degradation in the gastrointestinal tract. To design a formulation of sCT suitable for oral use. A water/oil/water (w/o/w) type multiple emulsion formulation was designed for oral application of sCT. sCT was placed in the inner water phase, and a protease inhibitor, aprotinin, was included in the outer water phase of this system to investigate the influence of protease inhibitors in the presence of sCT. The effectiveness of the formulation was evaluated in vitro by placing emulsion samples in a dialysis medium and in vivo by using a rat model. Incorporating sCT in the inner aqueous phase of a w/o/w emulsion appears to protect the peptide from enzymatic degradation. sCT was further protected by incorporating the protease inhibitor, aprotinin, in the outer aqueous phase. w/o/w emulsion formulations appear to be promising carrier systems for peptide-protein drugs.
    No preview · Article · Jan 2001 · Journal of Clinical Pharmacy and Therapeutics
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We studied surfactant-induced leakage of vesicles, comparing the efficacy of four surfactants with current or potential application in contraception and the prevention of sexually transmitted diseases:  nonoxynol-9 (N-9); the amphoteric mixture known as C31G; benzalkonium chloride (BZK); sodium dodecyl sulfate (SDS). Several features are generic to the membrane leakage process independent of the surfactant used. The kinetics of the leakage process is well-characterized by a single exponential rate of release, and the rate constant increases with surfactant concentration according to a power-law dependence. Notably, however, the formation of surfactant micelles serves to enhance the rate of vesicle leakage. A method for quickly changing the effective surfactant concentration in situ, and thus the rate of vesicle leakage, is presented. Specifically, methyl-β-cyclodextrin is added to the external aqueous solution and forms inclusion complexes with surfactant, effectively reducing the concentration of soluble surfactant. These studies show that the partitioning of surfactant between the aqueous solution and the lipid membrane is quick and certainly not a rate-limiting step in the membrane leakage process. We also show that the distribution of surfactant between the membrane and solution does not strictly follow a simple partitioning model. In comparing the membrane perturbing capabilities of the four surfactants, we find that C31G > BZK > N-9 SDS. Finally, our studies clearly show that the potencies of the surfactants toward membrane attack do not scale with the magnitudes of their critical micelle concentrations.
    Preview · Article · Jan 2003 · Langmuir
Show more